Joseph Eiden

3.3k citations

56 papers · 2.5k indexed · h-index 24

Impact in

Immunology and Allergy top 1%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Microbiology top 0.5%
- Bacterial Infections and Vaccines

Papers in ⓘ

Microbiology 22
- Bacterial Infections and Vaccines 20
Infectious Diseases 22
- Viral gastroenteritis research and epidemiology 10
- Antimicrobial Resistance in Staphylococcus 9
- Clostridium difficile and Clostridium perfringens research 7

Co-authors: Gary Van Nest (7 shared papers)Scott A. Halperin (2 shared papers)Bruce R. Smith (2 shared papers)Annaliesa S. Anderson (15 shared papers)Robert Lindblad (1 shared paper)Vicki L. Seyfert (1 shared paper)David H. Broide (1 shared paper)Susan Balcer-Whaley (1 shared paper)
Journals: Vaccine (8 papers)Journal of Allergy and Clinical Immunology (5 papers)Open Forum Infectious Diseases (5 papers)Virology (3 papers)The Lancet Infectious Diseases (3 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Joseph Eiden

56 papers receiving 2.3k citations

Peers

Countries citing papers authored by Joseph Eiden

Since Specialization

Citations

This map shows the geographic impact of Joseph Eiden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Eiden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Eiden more than expected).

Fields of papers citing papers by Joseph Eiden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Eiden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Eiden. The network helps show where Joseph Eiden may publish in the future.

Co-authors

The 25 scholars most cited alongside Joseph Eiden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joseph Eiden Line = papers co-authored together Joseph Eiden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Immunotherapy with a Ragweed–Toll-Like Receptor 9 Agonist Vaccine for Allergic Rhinitis New England Journal of Medicine ·Peter S. Creticos, John T. Schroeder, Robert G. Hamilton, Susan Balcer-Whaley, A.P. Khattignavong, Robert Lindblad, Henry Li, Robert L. Coffman, Vicki L. Seyfert, Joseph Eiden, David H. Broide	2006	438
2	A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant Vaccine ·Scott A. Halperin, Gary Van Nest, Bruce R. Smith, Simin Abtahi, Heather Whiley, Joseph Eiden	2003	200
3	Amb a 1–immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response Journal of Allergy and Clinical Immunology ·Meri K. Tulić, Pierre Fiset, Pota Christodoulopoulos, Patrice Vaillancourt, Martin Desrosiers, François Lavigne, Joseph Eiden, Qutayba Hamid	2004	191
4	Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA Journal of Allergy and Clinical Immunology ·F. Estelle R. Simons, Yasufumi Shikishima, Gary Van Nest, Joseph Eiden, Kent T. HayGlass	2004	148
5	Conjugation of protein to immunostimulatory DNA results in a rapid, long‐lasting and potent induction of cell‐mediated and humoral immunity European Journal of Immunology ·Helen Tighe, Kenji Takabayashi, David H. Schwartz, Robin Marsden, Lucinda Beck, Jacques Corbeil, Douglas D. Richman, Joseph Eiden, Hans L. Spiegelberg, Eyal Raz	2000	131
6	Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants The Journal of Pediatrics ·H. F. Clark, David I. Bernstein, Penelope H. Dennehy, Paul A. Offit, Michael E. Pichichero, John J. Treanor, Richard L. Ward, David L. Krah, Alan Shaw, Michael J. Dallas, Digilio Laura, Joseph Eiden, Nathalie Ivanoff, Karen M. Kaplan, Penny M. Heaton	2004	116
7	Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention Expert Review of Vaccines ·Gustavo H. Dayan, Naglaa Mohamed, Ingrid L. Scully, David Cooper, Elizabeth Begier, Joseph Eiden, Kathrin U. Jansen, Alejandra Gurtman, Annaliesa S. Anderson	2016	115
8	Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults Vaccine ·Scott A. Halperin, Simon Dobson, Shelly McNeil, Joanne M. Langley, Bruce R. Smith, Robyn McCall-Sani, Dan Levitt, Gary Van Nest, Daniel Gennevois, Joseph Eiden	2005	112
9	Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial The Lancet Infectious Diseases ·Peter Richmond, Helen Marshall, Michael D. Nissen, Qin Jiang, Kathrin U. Jansen, María Garcés‐Sánchez, Federico Martinón‐Torres, Johannes Beeslaar, Leszek Szenborn, Jacek Wysocki, Joseph Eiden, Shannon L. Harris, Thomas R. Jones, John L. Perez	2012	108
10	Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection Journal of Virology ·Richard B. Pyles, Debbie Higgins, Claudia Chalk, Anthony Zalar, Joseph Eiden, Carrie Brown, Gary Van Nest, Lawrence R. Stanberry	2002	94
11	SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies Vaccine ·Elizabeth Begier, David Seiden, Michael A. Patton, Edward T. Zito, Joseph M. Severs, David Cooper, Joseph Eiden, William C. Gruber, Kathrin U. Jansen, Annaliesa S. Anderson, Alejandra Gurtman	2017	57
12	A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults Vaccine ·Eric Sheldon, Nicholas Kitchin, Yahong Peng, Joseph Eiden, William C. Gruber, Erik W. Johnson, Kathrin U. Jansen, Michael W. Pride, Louise Pedneault	2016	56
13	Measles, Mumps, Rubella, and Varicella Combination Vaccine: Safety and Immunogenicity Alone and in Combination with Other Vaccines Given to Children Clinical Infectious Diseases ·C. J. White, Diane Stinson, BRENDA O. STAEHLE, I. Cho, Holly Matthews, A. Ngai, Paul M. Keller, Joseph Eiden, Barbara J. Kuter, (unknown)	1997	56
14	Diagnosis of Chlamydia pneumoniae Infection in Patients with Community-Acquired Pneumonia by Polymerase Chain Reaction Enzyme Immunoassay Clinical Infectious Diseases ·C A Gaydos, Joseph Eiden, David Oldach, Linda M. Mundy, Paul G. Auwaerter, M. L. Warner, Estil Vance, ALBERT A. BURTON, Thomas C. Quinn	1994	54
15	Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study Vaccine ·Robert W. Frenck, C. Buddy Creech, Eric Sheldon, David Seiden, Martin Kankam, James Baber, Edward T. Zito, Robin Hubler, Joseph Eiden, Joseph M. Severs, Shite Sebastian, Jasdeep S. Nanra, Kathrin U. Jansen, William C. Gruber, Annaliesa S. Anderson, Douglas Girgenti	2016	51
16	Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial Vaccine ·C. Buddy Creech, Robert W. Frenck, Eric Sheldon, David Seiden, Martin Kankam, Edward T. Zito, Douglas Girgenti, Joseph M. Severs, Frederick W. Immermann, Lisa K. McNeil, David Cooper, Kathrin U. Jansen, William C. Gruber, Joseph Eiden, Annaliesa S. Anderson, James Baber	2016	43
17	Rotavirus Immunoglobulin A Responses Stimulated by Each of 3 Doses of a Quadrivalent Human/Bovine Reassortant Rotavirus Vaccine The Journal of Infectious Diseases ·Richard L. Ward, David I. Bernstein, Vicki E. Smith, D. S. Sander, Alan Shaw, Joseph Eiden, Penny M. Heaton, Paul A. Offit, H. F. Clark	2004	39
18	Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine The Pediatric Infectious Disease Journal ·Shelly Senders, Prakash Bhuyan, Qin Jiang, Judith Absalon, Joseph Eiden, Thomas R. Jones, Laura J. York, Kathrin U. Jansen, Robert E. O’Neill, Shannon L. Harris, John Ginis, John L. Perez	2016	34
19	A Phase 2, Randomized, Active-controlled, Observer-blinded Study to Assess the Immunogenicity, Tolerability and Safety of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered With Tetanus, Diphtheria and Acellular Pertussis Vaccine and Serogroup A, C, Y and W-135 Meningococcal Conjugate Vaccine in Healthy US Adolescents The Pediatric Infectious Disease Journal ·Derek Muse, Shane Christensen, Prakash Bhuyan, Judith Absalon, Joseph Eiden, Thomas R. Jones, Laura J. York, Kathrin U. Jansen, Robert E. O’Neill, Shannon L. Harris, John L. Perez	2016	31
20	Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial The Lancet Infectious Diseases ·Helen Marshall, Peter Richmond, Johannes Beeslaar, Qin Jiang, Kathrin U. Jansen, María Garcés‐Sánchez, Federico Martinón‐Torres, Leszek Szenborn, Jacek Wysocki, Joseph Eiden, Shannon L. Harris, Thomas R. Jones, Su-San Lee, John L. Perez	2016	30

About Joseph Eiden

Joseph Eiden is a scholar working on Microbiology, Infectious Diseases, Immunology and Allergy, Epidemiology and Virology, having authored 56 papers that have together received 2.5k indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (20 papers), Pneumonia and Respiratory Infections (15 papers), Viral gastroenteritis research and epidemiology (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Allergic Rhinitis and Sensitization (7 papers), Clostridium difficile and Clostridium perfringens research (7 papers), Virology and Viral Diseases (7 papers) and Asthma and respiratory diseases (6 papers). The work is most often cited by research in Immunology and Allergy (554 citations), Microbiology (560 citations), Immunology (740 citations), Infectious Diseases (569 citations) and Dermatology (241 citations). Joseph Eiden has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Gary Van Nest, Scott A. Halperin, Bruce R. Smith, Annaliesa S. Anderson, Robert Lindblad, Vicki L. Seyfert, David H. Broide, Susan Balcer-Whaley, A.P. Khattignavong and Robert G. Hamilton. Their work appears in journals such as Vaccine, Journal of Allergy and Clinical Immunology, Open Forum Infectious Diseases, Virology and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact